Abstract
Early identification of the dermatologic manifestations of SARS-CoV-2 in perinatal and maternal-fetal-infant populations is essential for early intervention in the diagnosis, treatment, and prevention of short and long term sequelae. Although cutaneous signs of SARS-CoV-2 are less common in pregnant women, neonates, and infants, the recognition of related skin lesions with regard to timing, location, duration, and pattern can lead to determining disease severity. While many pediatric patients may be asymptomatic with negative SARS-CoV-2 testing, skin lesions may be the only clue of infection. SARS-CoV-2 infection in pregnancy can lead to severe life threatening illness and by understanding the cutaneous manifestations associated with SARS-CoV-2 infection, early diagnosis can be made with improved maternal-fetal outcomes. A wide array of dermatologic presentations associated with SARS-CoV-2 are reported in the literature. This review explores the expanding reports in the literature of the dermatologic presentations of skin lesions related to SARS-CoV-2 specifically in perinatal and maternal-fetal-infant health and the implications for management. The collaboration of the specialties of dermatology, pediatrics, obstetrics/gynecology, and infectious disease in the approach to SARS-CoV-2 disease can lead to a better understanding of the scope and presentation of this disease.
Subject
Pediatrics, Perinatology and Child Health
Reference93 articles.
1. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy Status — United States, January 22–October 3, 2020;Zambrano;MMWR Morb Mortal Wkly Rep,2020
2. Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy — sET-NET, 16 jurisdictions, March 29–October 14, 2020;Woodworth;MMWR Morb Mortal Wkly Rep,2020
3. Hospitalization of infants and children aged 0–4 years with laboratory-confirmed COVID-19 — cOVID-NET, 14 states, March 2020–February 2022;Marks;MMWR Morb Mortal Wkly Rep,2022
4. Epidemiology of neonatal COVID-19 in the United States;Devin;Pediatrics,2022